Mapping BCR/ABL1 Fusion in Philadelphia Negative CML
Author Information
Author(s): Virgili Anna, Brazma Diana, Reid Alistair G, Howard-Reeves Julie, Valgañón Mikel, Chanalaris Anastasios, De Melo Valeria AS, Marin David, Apperley Jane F, Grace Colin, Nacheva Ellie P
Primary Institution: Molecular Cytogenetics, Academic Haematology, Royal Free and UCL Medical School
Hypothesis
What are the genomic rearrangements associated with BCR/ABL1 fusion in Ph negative CML patients?
Conclusion
The study found that BCR/ABL1 formation resulted from both direct insertions and complex rearrangements, highlighting genetic heterogeneity in Ph negative CML.
Supporting Evidence
- BCR/ABL1 was located at 9q34 in 3 patients, 22q11 in 5 patients, and 22p11 in 1 patient.
- Different rearrangements were found in 3 patients, indicating genetic diversity.
- 6 patients showed a direct insertion mechanism for BCR/ABL1 formation.
Takeaway
Some people with a type of blood cancer have a special gene that can be found in different places in their DNA, which can make it harder to treat.
Methodology
FISH mapping was performed on bone marrow samples from 9 CML patients and the CML-T1 cell line using BAC clones.
Limitations
The study was limited by the availability of samples and the inability to assess all breakpoints due to lack of material.
Participant Demographics
7 females and 2 males with Ph negative BCR/ABL1 positive CML.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website